Persistent Platelet Reactivity in Acute Coronary Syndrome

Last updated: July 24, 2024
Sponsor: Hopital Lariboisière
Overall Status: Completed

Phase

N/A

Condition

Chest Pain

Heart Disease

Cardiac Disease

Treatment

N/A

Clinical Study ID

NCT02038309
PPRACS
  • Ages > 18
  • All Genders

Study Summary

Study of persistent platelet reactivity during acute coronary syndrome. Patients are included at admission to the hospital. Platelet aggregation is evaluated by platelet function testing after blood sampling during hospitalization. No changes in treatment is planned.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • acute coronary syndrome with elevation in troponin

Exclusion

Exclusion Criteria:

  • anticoagulant treatment

Study Design

Total Participants: 106
Study Start date:
January 01, 2013
Estimated Completion Date:
December 31, 2015

Study Description

Blood samples are performed on day 2 and 4 and collected with usual blood samples and analyzed by the laboratory. Maximal aggregation intensity and velocity are measured by light transmission aggregometry induced by arachidonic acid (AA) or adenosine diphosphate (ADP). Platelet function analyzer will be also used. No changes in treatment in response to the results is planned.

Connect with a study center

  • Department of Cardiology - Lariboisiere Hospital

    Paris, 75010
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.